Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers

计划入组 47 人 · 首次发布于 2010 年 9 月 13 日

Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)

计划入组 360 人 · 首次发布于 2018 年 6 月 15 日

Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole

计划入组 24 人 · 首次发布于 2011 年 11 月 9 日

Dihydroergotamine(Dhe-45, Migranal, Trudhesa)

C₃₃H₃₇N₅O₅ · Rx

DHES-0815A

Prasterone(Intrarosa)

C₁₉H₂₈O₂

The Oncology Institute

TMC the metals

The Kroger

Amneal Advances Migraine and Diabetes Treatments with DHE Autoinjector and Exenatide Approval

Amneal Advances Migraine and Diabetes Treatments with DHE Autoinjector Resubmission and Exenatide Approval

FDA Approves Brekiya: First DHE Autoinjector for Acute Migraine and Cluster Headache Treatment